News & numbers


The pharmaceutical industry continues to see heavy investment in research and development (R&D) to improve existing products and bring new drugs to market. For leading companies in the industry, investing in R&D is paramount as a strategy to differentiate themselves from competitors and meet the evolving healthcare needs of the global population. Below, we look at the top 20 biggest spenders in the business and rank them by the amount they invest in R&D.


Ranking 11 12 13 14 15 16 17 18 19 20


$754.16bn $539.56bn


The amount of combined revenue that the top 20 R&D spenders in the pharmaceutical industry generated in 2022.


Or 72%, the amount of combined revenue that the top 10 R&D spenders in the pharmaceutical industry contributed in 2022.


Clinical Trials Insight / www.worldpharmaceuticals.net Company R&D expenditure $6.51bn $5.05 $5bn $4.8bn $4.43bn $3.59bn $3.4bn $3.4bn $2.54bn $2.29bn Turnover $58.05bn $24.15 $27.28bn $29.96bn $26.32bn $12.17bn $19.25bn $19.26bn $8.93bn $8.57bn


$144.29bn $101.15bn


The combined spending on R&D by the same top 20 companies in the pharmaceutical industry in 2022.


The combined spending on R&D by the same top 10 companies in the pharmaceutical industry in 2022.


19% 13%


Percentage of total revenue spent on R&D


11% 21% 18% 16% 17% 29% 18% 18% 28% 27%


The total revenue percentage invested on R&D by the top 20 pharmaceutical companies in 2022.


The total revenue percentage invested on R&D by the top 10 pharmaceutical companies in 2022.


7


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41